US Activist Hedge Fund Institutional SEC 13D 13G — June 15, 2026

15-06-2026

GreenWood Investors LLC filed an amended Schedule 13D with the SEC on June 15, 2026, disclosing a 7.1% beneficial ownership stake in Jack in the Box Inc. (JACK) as of June 11, 2026. The filing details recent open-market purchases and sales of common stock over the past 60 days, with total acquisition cost of approximately $23.3 million. While the fund increased its position overall, it also executed some small sales during the period, indicating active portfolio management.

• · The filing is an amendment (No. 1) to the initial Schedule 13D filed on November 18, 2025.
• · GreenWood Investors LLC has no voting power over certain shares held by GreenWood Accounts, but has dispositive power.
• · Some shares are held in margin accounts and pledged as collateral for debit balances; margin interest is based on broker's call rate.
• · Recent transactions include purchases on 6/11/2026 (8,000 shares at $12.18), 6/10/2026 (16,000 shares at $12.33), and 6/9/2026 (8,000 shares at $11.98), as well as a sale of 502 shares on 6/5/2026 at $11.19 and a transfer of 226 shares on the same date.
• · The fund also sold 3,971 shares on 5/19/2026 at $11.21, indicating some profit-taking or rebalancing.

15-06-2026

B. Luke Weil and Willow Lane Sponsor, LLC filed a Schedule 13D disclosing beneficial ownership of 3,906,023 shares of Boost Run Inc. (BRUN) Class A Common Stock, representing 12.25% of the outstanding shares as of June 1, 2026. The filing details a transfer of 1,272,885 shares and 1,101,986 Private Warrants to Goodrich ILMJS LLC on June 9, 2026, reducing the Sponsor's holdings. Weil serves as a director and consultant, with potential additional compensation of up to 336,000 shares tied to stock price performance thresholds.

• · The Sponsor originally acquired 4,628,674 Founder Shares for approximately $25,000 ($0.005 per share) and 4,007,222 Private Warrants at $1.00 per warrant.
• · On September 15, 2025, the Sponsor transferred 27.5% of its Founder Shares and Private Warrants to Goodrich ILMJS LLC at $1.75 per Founder Share.
• · The Business Combination between Willow Lane Acquisition Corp. and Boost Run Holdings, LLC closed on May 8, 2026.
• · Weil's consulting shares vest in three tranches of 112,000 shares each upon VWAP thresholds of $12.00, $14.50, and $17.50.
• · Sponsor Earnout Shares (1,125,000) are subject to VWAP thresholds of $12.50, $15.00, and $17.50 over a three-year period.
• · No transactions in Class A Common Stock were effected by the Reporting Persons during the past 60 days except the transfer to SPV.

15-06-2026

InterPrivate Acquisition Management V LLC, its controlling entity IPAM (M) V LLC, and Chairman/CEO Ahmed Fattouh collectively disclosed beneficial ownership of 5,396,250 ordinary shares (21.00% of outstanding) of InterPrivate Investment Partners V, Inc. in a Schedule 13D filed June 15, 2026. The sponsor acquired 5,031,250 Class B shares for $25,000 on December 10, 2025, and 365,000 private placement units (each unit = 1 Class A share + 1/3 warrant) for $3,650,000 in connection with the IPO completed June 5, 2026. There are no recent transactions in the ordinary shares, and the reporting persons have no current plans for material corporate changes such as mergers, asset sales, or board changes beyond pursuing a business combination target.

• · Class B ordinary shares (5,031,250) were issued to Sponsor on December 10, 2025 for $25,000 aggregate purchase price.
• · Sponsor purchased 365,000 private placement units at $10.00 per unit (total $3,650,000) simultaneously with IPO closing on June 5, 2026.
• · Underwriters purchased 175,000 units at $10.00 per unit (total $1,750,000) in the IPO.
• · Each private unit consists of one Class A ordinary share and one-third of one warrant (exercise price $11.50).
• · The reporting persons hold no shared voting or dispositive power; each has sole power over all 5,396,250 shares.
• · No transactions in ordinary shares were effected during the 60 days prior to the filing date.
• · Private placement units and underlying securities are subject to a lock-up until 30 days after completion of initial business combination.
• · Sponsor is party to a Registration Rights Agreement and a Letter Agreement (voting, non-redemption, transfer restrictions) with the issuer.

15-06-2026

Jupiter Asset Management Ltd and its Jupiter Gold & Silver Fund filed a Schedule 13G indicating beneficial ownership of 4,260,536 common shares of Collective Mining Ltd., representing a 5.02% stake as of August 12, 2025. The filing was submitted late (June 15, 2026 vs. required deadline) due to a monitoring error where Canadian thresholds were applied instead of U.S. thresholds, and the filer notes it is reviewing controls to prevent recurrence. No negative trends or declines are reported in this ownership disclosure.

• · The Schedule 13G was filed under Rule 13d-1(c), indicating the shares were acquired and held in the ordinary course of business not with the purpose of influencing control.
• · Jupiter Gold & Silver Fund holds the same 4,260,536 shares as the reporting entity, with shared voting and dispositive power.
• · The filing explicitly states it is being submitted after the prescribed deadline, citing a monitoring system error that used Canadian instead of U.S. thresholds.
• · The issuer's headquarters was recently changed to 82 Richmond Street East, 4th Floor, Toronto, Ontario, Canada, which triggered a review and discovery of the oversight.
• · The filer certified it is not acquiring or holding the securities to change or influence control of the issuer.

15-06-2026

White Lion Capital LLC filed a Schedule 13G with the SEC on June 15, 2026, disclosing beneficial ownership of 128,879 shares of CID Holdco, Inc. common stock, representing an 8.9% stake as of June 5, 2026. The shares were acquired pursuant to a purchase agreement, and the filing indicates the securities are not held for the purpose of changing or influencing control of the issuer.

• · The Schedule 13G was filed under Rule 13d-1(c), indicating the filer is a passive investor.
• · White Lion Capital LLC is based in Encino, California, and is organized under Nevada law.
• · The filing certifies that the securities were not acquired with the purpose of changing or influencing control of CID Holdco, Inc.

15-06-2026

Harel Insurance Investments & Financial Services Ltd. filed a Schedule 13G with the SEC on June 15, 2026, reporting beneficial ownership of 5,700,478 ordinary shares of Tower Semiconductor Ltd, representing 5.1% of the 112,824,944 shares outstanding as of March 31, 2026. However, Harel disclaims beneficial ownership of all but 173,920 shares held for its own account, as the majority are held on behalf of clients and managed by independent subsidiaries.

• · The filing is made under Rule 13d-1(c), indicating passive investment intent.
• · Harel certifies that the securities were not acquired to change or influence control of the issuer.
• · The filing date is June 15, 2026, with the event date of June 10, 2026.

15-06-2026

Chan Wai Ho and Chen Sze Hon Johnson sold an aggregate of 1,638,250 Class A ordinary shares and 1,000,000 Class B ordinary shares of Magic Empire Global Ltd (MEGL) to a group of five purchasers, representing 52.1% of total issued share capital and 89.9% of total voting rights. The sale closed on June 11, 2026, with Chan Wai Ho receiving $0.7533 per Class A share and $15.0659 per Class B share for his portion of 997,500 Class A and 600,000 Class B shares. This transaction results in a change of control of MEGL, with the sellers reducing their beneficial ownership to zero.

• · The share purchase agreement was dated May 22, 2026, and the closing occurred on June 11, 2026.
• · The purchasers include five entities/individuals: Fu Kam Holdings Limited, Easefound Investment Limited, Jming International Trade Company Limited, Quick Cash Technology Limited, and Xu Xiaoxi.
• · The sellers' ownership prior to the sale was 52.1% of total issued share capital and 89.9% of total voting rights.
• · The filing indicates that the sellers' beneficial ownership after the transaction is zero (0.00 shares reported).
• · A deposit was held in escrow under a Custodian Agreement dated April 24, 2026, involving Huang Shufen and the sellers' solicitors.

15-06-2026

Helena Global Investment Opportunities 1 Ltd. filed an amended Schedule 13G with the SEC on June 15, 2026, disclosing a zero beneficial ownership position (0 shares, 0%) in DevvStream Corp. as of June 8, 2026. The filing indicates that the investment manager has fully exited its position in the company, changing from a prior filer status to effectively being no longer a major shareholder.

• · The filing date is June 15, 2026, with the event date of beneficial ownership change being June 8, 2026.
• · Helena Global Investment Opportunities 1 Ltd. is organized under the laws of the Cayman Islands and lists its business address in Grand Cayman.
• · The filing is made pursuant to Rule 13d-1(c), indicating the filer is a passive investor not seeking to influence control of the issuer.
• · No other person is reported as having shared voting or dispositive power over the securities (sole voting power, shared voting power, sole dispositive power, and shared dispositive power are all 0).

15-06-2026

Linden Capital L.P. and related entities filed a Schedule 13G with the SEC on June 15, 2026, disclosing beneficial ownership of 1,250,000 Class A Ordinary Shares of Snow Rothschild Acquisition Corp., representing approximately 5.5% of shares outstanding as of June 12, 2026. The filing is a passive investment disclosure under Rule 13d-1(c), with no intent to change or influence control of the issuer.

• · The filing is made under Rule 13d-1(c), indicating passive investment intent.
• · Linden Capital L.P. is a Bermuda limited partnership; Linden GP LLC is a Delaware LLC; Linden Advisors LP is a Delaware limited partnership.
• · Mr. Wong is a citizen of China (Hong Kong) and the United States.
• · The principal business address for Linden Capital is Victoria Place, 31 Victoria Street, Hamilton HM10, Bermuda.
• · The principal business address for Linden Advisors, Linden GP, and Mr. Wong is 590 Madison Avenue, 32nd Floor, New York, New York 10022.
• · The filing includes a Joint Filing Agreement among the reporting persons.

15-06-2026

Richard N. Barton filed Amendment No. 4 to his Schedule 13D on June 15, 2026, reporting beneficial ownership of 4,194,265 shares of Zillow Group Class A Common Stock (9.2% of the class) and aggregate voting power of approximately 36.4% due to his Class B shares (10 votes each). The filing reflects an increase in his ownership percentage resulting from the company's repurchases of Class A Common Stock, though Barton did not effect any transactions in Class A shares during the past 60 days.

• · Barton's beneficial ownership includes 190,536 shares of Class A Common Stock and 3,423,845 shares issuable upon conversion of Class B Common Stock owned directly, plus 339,880 shares issuable upon conversion of Class B Common Stock owned indirectly through Barton Ventures II, LLC.
• · Barton has sole voting and dispositive power over all reported shares except 220,004 shares of the Barton Trust for which he is co-trustee but lacks voting power.
• · The filing is an amendment to reflect increased ownership percentage due to Zillow's repurchases of Class A Common Stock, not due to any purchases by Barton.
• · Class B Common Stock carries ten votes per share, while Class A Common Stock carries one vote per share.

15-06-2026

ValueAct entities filed Amendment No. 1 to Schedule 13D, disclosing that as of June 15, 2026, they have ceased to be beneficial owners of more than 5% of Liberty Live Holdings, Inc. common stock. The filing details a series of sales of Series A common stock by ValueAct Master Fund and ValueAct Strategic Global Master Fund during the preceding 60 days, reducing their aggregate beneficial ownership to below 5%.

• · ValueAct Master Fund sold a total of 421,921 shares of Series A common stock between May 6 and June 15, 2026, at prices ranging from $88.81 to $98.58 per share.
• · ValueAct Strategic Global Master Fund sold a total of 26,356 shares of Series A common stock in the same period at similar prices.
• · The filing indicates that the reporting persons' obligation to file Schedule 13D has been terminated as they no longer beneficially own more than 5% of the issuer's common stock.

15-06-2026

Baker Bros. Advisors LP filed an amended Schedule 13D disclosing that Felix J. Baker, Ph.D., a managing member of the Adviser GP, was elected to the board of directors of BeOne Medicines Ltd. (formerly BeiGene, Ltd.) on June 11, 2026, and serves as Lead Director. Concurrently, two previous directors who were employees of the Adviser, Michael Goller and Ranjeev Krishana, did not stand for re-election and their board service expired. The Baker Bros. group collectively beneficially owns 115,457,154 ordinary shares (8.0% of the outstanding shares), while FBB3 LLC holds 144,517 ordinary shares (0.01%).

• · Felix J. Baker was granted 18,980 RSUs that vest solely into ordinary shares on the earlier of the first anniversary of the grant date or the next annual general meeting, with vesting ceasing if he resigns or ceases to be a director.
• · Michael Goller and Ranjeev Krishana each hold 463,437 share options with various exercise prices ranging from $2.84 to $26.53 per ordinary share, expiring between December 2026 and June 2029.
• · On May 21, 2026, Michael Goller and Ranjeev Krishana each received 10,985 ordinary shares from vesting of RSUs; the following day, 2,743 shares were sold for Goller at $23.8512 per share and 2,756 shares for Krishana at $23.7905 per share to pay mandatory Swiss withholding tax.
• · The Funds (Baker Brothers Life Sciences, L.P. and 667, L.P.) directly hold 114,387,689 ordinary shares through 8,799,053 ADS.
• · The policy of the Funds and the Adviser does not permit managing members or full-time employees to receive compensation for serving as directors; instead, the Funds are entitled to the pecuniary interest in any director compensation.

15-06-2026

A group of beneficial owners of Power REIT's Series A Preferred Stock, holding approximately 11.5% of the outstanding shares, filed Amendment No. 5 to Schedule 13D on June 15, 2026. The group reiterated a demand for a special meeting of preferred stockholders to elect two additional trustees, citing the Trust's failure to pay dividends for more than six quarterly periods. The filing also discloses additional open-market purchases of Series A Preferred Stock since late May 2026, increasing the group's aggregate beneficial ownership to 38,717 shares.

• · The reporting group's aggregate beneficial ownership of Series A Preferred Stock is 38,717 shares, representing 11.5% of the 336,944 outstanding shares as of March 31, 2026.
• · Bradley & Daytona and Alexander Kachmar directly own 25,406 shares; the Cacciapaglia trusts own 13,311 shares.
• · Since the previous filing on May 26, 2026, Bradley & Daytona and Alexander Kachmar purchased an additional 1,367 shares of Series A Preferred Stock in open-market transactions between May 27 and June 12, 2026, at prices ranging from $7.62 to $10.50 per share.
• · The group delivered a second formal demand on June 15, 2026, requiring Power REIT to establish a record date and meeting date for the special election by 12:00 p.m. ET on June 19, 2026.
• · The group has nominated Alexander Kachmar and David Cacciapaglia as trustee candidates for the special election.

15-06-2026

Albion River Management LLC, Ignium II, LP, and Darren Farber filed an amended Schedule 13D disclosing a reduced beneficial ownership of 287,034 shares (4.01%) of National Presto Industries Inc. as of June 15, 2026, down from a prior peak of 395,080 shares. The filing details a series of open-market sales in May and June 2026, with prices ranging from $132.12 to $142.53 per share, and notes that the group ceased to be a >5% holder as of May 20, 2026. The reporting persons initially acquired shares believing they were undervalued and engaged in discussions with the issuer in late March 2026, but subsequently sold a portion of their holdings.

• · The reporting persons initially acquired 362,250 shares and later purchased ~33,000 additional shares in the open market, with the last purchase in January 2026, bringing aggregate ownership to 395,080 shares.
• · The group engaged in discussions with the issuer regarding strategy, including a meeting in late March 2026.
• · Sales occurred on 10 separate trading days between May 20 and June 11, 2026, with the largest single sale of 40,559 shares on May 20 at $142.53.
• · The group ceased to be beneficial owners of more than 5% of outstanding shares as of May 20, 2026.
• · All shares are held by Ignium II, LP; Albion River Management LLC serves as investment manager, and Darren Farber is the sole managing partner.

15-06-2026

James L. Stafford filed a Schedule 13G with the SEC on June 15, 2026, disclosing beneficial ownership of 2,474,253 shares of Datacentrex, Inc. (formerly THUMZUP MEDIA Corp) common stock, representing approximately 6.4% of the outstanding shares. The filing indicates the shares are held for investment purposes without intent to change or influence control of the issuer.

• · The Schedule 13G was filed pursuant to Rule 13d-1(c), indicating passive investment intent.
• · James L. Stafford's address is in Nassau, Bahamas (non-US location).
• · The filing is dated June 15, 2026, and the ownership became effective on April 23, 2026.
• · The issuer was formerly known as THUMZUP MEDIA Corp until a name change on March 26, 2021.

15-06-2026

Joshua S. Boger, Ph.D., filed an amended Schedule 13D with the SEC on June 15, 2026, disclosing beneficial ownership of 2,204,143 shares of CervoMed Inc. common stock, representing approximately 19.99% of the outstanding shares. The filing details a June 11, 2026 private placement in which the Joshua S. Boger 2021 Trust purchased 955,414 units at $3.14 per unit, each consisting of one share of common stock, one Series B warrant (exercise price $3.32, 5-year term), and one Series C warrant (exercise price $3.14, 1-year term). The warrants include a 19.99% maximum ownership limitation, restricting the Reporting Person from exercising warrants beyond 2,204,143 shares.

• · The filing amends a Schedule 13D originally filed on February 9, 2024, and previously amended on February 26, 2024.
• · Boger's beneficial ownership includes shares held directly (216,817), by the JSB 2021 Trust (1,600,117), by the ASB 2021 Trust (195,748), and warrants/options.
• · The Series B warrants expire five years from issuance (June 2026), and the Series C warrants expire one year from issuance.
• · The warrants contain a 19.99% maximum ownership limitation, preventing exercise beyond 2,204,143 shares.
• · Boger disclaims beneficial ownership of securities held by the trusts except for his pecuniary interest.
• · The private placement closed on June 11, 2026, and was reported in a Form 8-K filed June 10, 2026.

15-06-2026

Millennium Management LLC, together with Millennium Group Management LLC and Israel A. Englander, filed a Schedule 13G on June 15, 2026, disclosing beneficial ownership of 890,366 shares of Tonix Pharmaceuticals Holding Corp. common stock, representing a 5.6% stake as of June 9, 2026. The filing is made under Rule 13d-1(c) and includes a joint filing agreement among the reporting entities.

• · The Schedule 13G was filed under Rule 13d-1(c), indicating the securities were not acquired with the purpose of changing or influencing control of the issuer.
• · The filing includes a Joint Filing Agreement dated June 12, 2026, among Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander.
• · The reporting persons disclaim beneficial ownership of the securities held by the underlying entities, except to the extent of their pecuniary interest.

15-06-2026

Davidson Kempner Capital Management LP and related entities filed a Schedule 13G with the SEC on June 15, 2026, disclosing beneficial ownership of 5,223,970 shares of BlockchAIn Digital Infrastructure, Inc. common stock, representing 7.36% of the 70,979,467 shares outstanding. The filing indicates the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing control of the issuer.

• · The filing is made pursuant to Rule 13d-1(c), indicating the filer is a passive investor not seeking control.
• · The beneficial ownership is calculated based on 70,979,467 shares outstanding as of June 8, 2026, after the completion of a public offering.
• · Anthony A. Yoseloff is the ultimate controlling person for all reported shares through his role at DKCM.
• · The filing includes a joint filing agreement among all reporting persons.

15-06-2026

Engine Capital, L.P. and related entities filed an amended Schedule 13D with the SEC on June 15, 2026, disclosing an aggregate beneficial ownership of 686,315 common shares (approximately 6.3%) of Civeo Corp. However, the filing reveals that Engine Capital and its affiliates have been actively selling shares over the past 60 days, with 21 transactions totaling over 150,000 shares sold at prices ranging from $30.01 to $35.16 per share, indicating a reduction in their position.

• · Engine Capital, L.P. sold 21,196 shares on April 17, 2026 at $30.0084 per share.
• · Engine Capital, L.P. sold 25,966 shares on June 12, 2026 at $34.5298 per share.
• · Engine Capital, L.P. sold 18,100 shares on June 15, 2026 at $34.1040 per share.
• · Engine Jet Capital, L.P. sold 2,160 shares on June 12, 2026 at $34.5298 per share.
• · Engine Lift Capital, LP sold 2,593 shares on June 12, 2026 at $34.5298 per share.
• · All reported transactions in the past 60 days were sales; no purchases were disclosed.
• · The filing is an amendment (No. 6) to the original Schedule 13D.

15-06-2026

On June 15, 2026, a group of entities led by Invus Global Management, LLC and Raymond Debbane filed a Schedule 13G disclosing collective beneficial ownership of 403,586 shares (9.99%) of Eloxx Pharmaceuticals, Inc. The filing includes Invus Public Equities, L.P. (directly holding 350,525 shares and 43,816 pre-funded warrants) and Avicenna Life Sci Master Fund LP (directly holding 49,475 shares and 6,184 warrants), with all warrants exercisable at $0.01 per share with no expiration but subject to a 9.99% beneficial ownership limitation. The filing certifies the securities were not acquired to change or influence control of the issuer.

• · The warrants are subject to a Beneficial Ownership Limitation of 9.99%, which can be changed at the holder's election upon 61 days' notice to the issuer.
• · The filing is made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, indicating a passive investment intent.
• · The Reporting Persons disclaim beneficial ownership of any shares whose issuance would violate the Beneficial Ownership Limitation.
• · The percentage calculations are based on 4,036,314 shares outstanding as of June 10, 2026, plus 3,586 shares issuable upon exercise of certain warrants (the maximum allowed under the limitation).
• · A Joint Filing Agreement under Rule 13d-1(k) was executed by all Reporting Persons.

15-06-2026

OrbiMed Advisors LLC and its affiliates filed an amended Schedule 13D disclosing a 9.99% beneficial ownership stake in Shattuck Labs, Inc. as of June 15, 2026. The filing details the conversion of 2025 Common Warrants into pre-funded warrants on June 8, 2026, and participation in a June 2026 public offering where OrbiMed entities purchased 1,250,000 pre-funded warrants. The reporting persons disclaim any current plans for extraordinary corporate transactions or changes in control.

• · The filing is an amendment to a Schedule 13D originally filed on September 2, 2025.
• · OrbiMed entities purchased 1,041,667 (OPI IX) and 208,333 (Genesis) 2026 Pre-Funded Warrants in the June 2026 public offering.
• · OPI IX holds 24,257,041 pre-funded warrants that are not exercisable due to a 9.99% blocker provision.
• · Genesis holds 4,851,408 pre-funded warrants that are not exercisable due to the blocker.
• · The reporting persons disclaim any plans for mergers, asset sales, board changes, or other extraordinary transactions.

15-06-2026

Juniper Investment Company and affiliated entities filed Amendment No. 9 to their Schedule 13D, disclosing a reduction in their aggregate beneficial ownership of Lincoln Educational Services Corp (LINC) to 6.8% (2,141,723 shares) from a previously higher stake, following open-market sales. Between February 27, 2026, and June 12, 2026, Juniper Targeted Opportunity Fund sold 355,345 shares for approximately $15.6 million, while Managing Member John A. Bartholdson received 3,515 restricted shares valued at $155,000 on May 7, 2026.

• · Juniper Fund sold shares on May 14, 15, June 3, 4, 11, and 12, 2026, with weighted-average prices ranging from $46.88 to $51.16.
• · The highest sale volume on a single day was 81,504 shares on June 3, 2026 at $50.10 weighted average.
• · John A. Bartholdson's restricted stock award was priced at $44.10 per share, the closing price on the grant date.
• · Juniper Targeted Opportunities, L.P. held 0 shares as of the filing date.
• · The Indemnification Agreement with John A. Bartholdson was originally entered on November 14, 2019.

15-06-2026

RA Capital Management, L.P. and affiliated entities filed a Schedule 13D/A on June 15, 2026, disclosing aggregate beneficial ownership of 17,811,623 shares of Artiva Biotherapeutics, Inc. common stock, representing 36.6% of the outstanding shares. The filing details open market purchases by RA Capital Healthcare Fund, L.P. between June 9 and June 15, 2026, totaling approximately 1,434,155 shares at prices ranging from $6.77 to $9.00 per share. However, the Fund holds pre-funded warrants for 2,170,138 additional shares that are currently blocked from exercise due to a 9.99% beneficial ownership limitation.

• · The Fund purchased 479,039 shares on June 9, 2026 at weighted average price of $6.91; 103 shares on June 10 at $7.00; 548,580 shares on June 11 at weighted average $7.91; 391,019 shares on June 12 at weighted average $8.57; and 15,414 shares on June 15 at weighted average $8.99.
• · Pre-funded warrants for 2,170,138 shares are subject to a Beneficial Ownership Blocker preventing exercise above 9.99% ownership.
• · RA Capital serves as investment adviser for the Fund, Nexus Fund, Nexus Fund III, and a separately managed account, with delegated voting and disposal power.
• · The filing is an amendment to the original Schedule 13D filed July 9, 2024, with prior amendments on September 3, 2024 and May 13, 2026.

15-06-2026

RA Capital Management, L.P. and affiliated entities filed a Schedule 13D/A disclosing aggregate beneficial ownership of 5,138,703 shares of Werewolf Therapeutics, Inc. (HOWL) common stock, representing 10.6% of outstanding shares as of June 15, 2026. However, the filing reveals that RA Capital entities sold a total of 977,437 shares in open market transactions between June 9 and June 15, 2026, at prices ranging from $0.36 to $0.41 per share, indicating a significant reduction in their position.

• · The filing is Amendment No. 9 to the original Schedule 13D filed on May 6, 2021.
• · RA Capital entities sold shares in multiple transactions over five trading days (June 9-12 and June 15, 2026).
• · Sale prices ranged from $0.36 to $0.41 per share, with weighted average prices between $0.37 and $0.40.
• · The Fund and Nexus Fund II have delegated voting and investment power to RA Capital, which cannot be revoked on less than 61 days' notice.
• · No transactions were effected in the 60 days prior to the filing date except those listed.
• · The percentage ownership increase reported is attributed to a change in the number of outstanding shares, not additional purchases.

15-06-2026

Saba Capital Management, L.P. and related parties filed an amended Schedule 13D disclosing a 5.35% beneficial ownership stake in Gabelli Dividend & Income Trust (GDV-PK), representing 4,715,534 common shares. The filing reveals that Saba Capital has been actively selling shares in the open market over the past 60 days, with 27 sell transactions totaling approximately 380,959 shares at prices ranging from $28.72 to $29.42. The total cost to acquire the reported shares was approximately $107.7 million.

• · The filing is Amendment No. 4 to Schedule 13D, amending Items 3, 5, and 7.
• · Saba Capital's business address is 405 Lexington Avenue, 58th Floor, New York, NY 10174.
• · Funds for share purchases were derived from subscription proceeds, capital appreciation, and margin account borrowings.
• · Shares held in margin accounts are pledged as collateral for debit balances.
• · All reported trades were executed in the open market.
• · The filing date is June 15, 2026, with the event date requiring filing being June 11, 2026.
• · Saba Capital has not been convicted in any criminal proceeding or been party to any relevant civil proceeding in the last five years.

15-06-2026

On May 29, 2026, Neo-Concept International Group Holdings Ltd (NCI) underwent a major ownership restructuring where two affiliated entities, Neo-Concept (BVI) Limited and Ample Excellence Limited, disposed of their entire shareholdings in the Company for total cash consideration of $3,614,500 ($3,221,700 and $392,800 respectively). Following these divestitures, beneficial ownership of the Company is now concentrated under Ms. Eva Yuk Yin Siu (Chairlady, CEO, and Director) through her wholly-owned Asset Empire International Ltd, which holds 87.71% of Splendid Vibe Ltd, which in turn owns the entire share capital of the divesting entities. However, this restructuring represents a significant simplification of the ownership structure as two intermediate corporate entities (Neo-Concept BVI and Ample Excellence) no longer directly hold any shares, while Ms. Siu's ultimate control remains in place.

• · Ms. Eva Yuk Yin Siu, through her wholly-owned Asset Empire International Limited, holds 87.71% of Splendid Vibe Limited, which owns 100% of both Neo-Concept (BVI) and Ample Excellence.
• · As of May 29, 2026, Neo-Concept (BVI) held 0 shares and Ample Excellence held 0 shares in the Company, having disposed of their entire holdings on that date.
• · As of May 29, 2026, the Company had 2,289,253 Class A ordinary shares and 75,000 Class B ordinary shares issued and outstanding.
• · Neo-Concept (BVI) originally received 1,000,000 shares for nil consideration on Oct 29, 2021, and later acquired 10,250,000 shares for $1,025.
• · Prior transfers: Neo-Concept (BVI) transferred 561,375 shares to Au Lai Ming for HK$4,990,000 and 337,500 shares to Chan Kim Sun for HK$3,000,000 on March 8, 2022.
• · No Reporting Persons have been convicted in any criminal proceeding (excluding traffic violations) or been party to securities law violations in the past five years.
• · The Reporting Persons have no present plans or proposals for any of the actions described in Item 4 of Schedule 13D (e.g., extraordinary corporate transactions, changes in board, etc.).

15-06-2026

Fresenius Medical Care Holdings, Inc. and Fresenius Medical Care AG filed Amendment No. 9 to their Schedule 13D, reporting continued beneficial ownership of 18,312,735 shares of Humacyte, Inc. common stock. However, their ownership percentage decreased from 8.4% to 6.8% due solely to an increase in the issuer's outstanding shares, which rose to 269,638,156 shares as of June 12, 2026. The filing also notes the appointment of Mollie Miller as Vice President and Assistant Treasurer of FMCH and confirms that neither Fresenius entity has acquired or disposed of any shares since September 2021.

• · The decrease in ownership stake from 8.4% to 6.8% is entirely dilution-driven; Fresenius has not bought or sold any Humacyte stock since September 2021.
• · Total outstanding shares increased by 47,619,048 shares due to a secondary offering (prospectus supplement dated June 10, 2026).
• · Mollie Miller was appointed VP and Assistant Treasurer of FMCH effective May 1, 2026; she is a U.S. citizen and has no relevant criminal or securities-law history.
• · FMCH holds sole voting and dispositive power over all 18,312,735 shares; FME AG is the indirect sole shareholder and may be deemed beneficial owner.

15-06-2026

Xlife Sciences AG filed a Schedule 13D disclosing beneficial ownership of 23,029,967 ordinary shares (16.3%) of Veraxa Biotech Holding AG following the closing of a business combination on June 8, 2026. The shares were acquired in connection with the merger of Voyager Acquisition Corp. and Veraxa Biotech AG. The filing also details earnout provisions that could provide up to 5,000,000 additional shares per fiscal year if VWAP targets of $11.00, $12.50, and $14.00 are met by December 31, 2026, 2027, and 2028, respectively.

• · The business combination closed on June 8, 2026, with Voyager merging into Merger Sub and Veraxa merging into PubCo, which then changed its name to Veraxa Biotech AG.
• · The Reporting Person (Xlife Sciences AG) is a Switzerland citizen and its principal business address is Talacker 35, 8001 Zurich, Switzerland.
• · The Business Combination Agreement was originally entered into on April 22, 2025, and amended on October 18, 2025, and February 2, 2026.
• · The Voting, Support and Lock-Up Agreement restricts transfer of certain PubCo Ordinary Shares for a specified period after closing.
• · Earnout Shares are contingent on VWAP thresholds: $11.00 by Dec 31, 2026; $12.50 by Dec 31, 2027; $14.00 by Dec 31, 2028.

15-06-2026

Cheddi Rai Bharrat filed an amended Schedule 13D disclosing that he no longer beneficially owns any shares of Visium Technologies, Inc. (VISM) common stock, following the termination of a non-binding letter of intent (LOI) with ConnexUS AI and his resignation as officer and director effective June 8, 2026. The change resulted from a Mutual Release, Settlement, and Termination Agreement that also included mutual general releases and confirmed no further obligations between the parties. This exit filing reduces the reporting person's beneficial ownership from a previously undisclosed amount to zero.

• · The LOI with ConnexUS AI was terminated via a Mutual Release, Settlement, and Termination Agreement dated on or about June 8, 2026.
• · Bharrat resigned from all officer, director, employee, and consultant positions with Visium effective June 8, 2026.
• · The Release Agreement includes mutual general releases of all claims related to the LOI and confirms no further payment or performance obligations.
• · The filing references the Issuer's Form 8-K filed June 10, 2026, for the full text of the Release Agreement.
• · The reporting person disclaims any continuing beneficial ownership interest in the Issuer.

15-06-2026

Andy Ni filed a Schedule 13G with the SEC on June 15, 2026, reporting beneficial ownership of 60,000 common shares of Aditxt, Inc. (ADTX), representing a 7.3% stake in the company. The filing indicates the shares were acquired and are held for investment purposes, not to influence control of the issuer.

• · The filing was made under Rule 13d-1(c), indicating passive investment intent.
• · Andy Ni has sole voting and dispositive power over all 60,000 shares.
• · The filing date is June 15, 2026, with the event date of beneficial ownership as June 10, 2026.

15-06-2026

Zhang Xiaofan filed a Schedule 13G with the SEC on June 15, 2026, disclosing beneficial ownership of 1,873,388 shares of VYNE Therapeutics Inc. common stock, representing a 5.6% stake. The filing indicates the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing control of the issuer.

• · The filing is made under Rule 13d-1(c), indicating passive investment intent.
• · Zhang Xiaofan's address is in Shanghai, China.
• · The shares have a par value of $0.0001 per share.
• · The filing date is June 15, 2026, with an event date of June 8, 2026.

15-06-2026

SIT Investment Associates Inc and SIT Fixed Income Advisors II LLC filed Amendment No. 6 to Schedule 13D, disclosing beneficial ownership of 10,641,285 shares (32.7%) of MFS Government Markets Income Trust as of June 12, 2026. The filing details numerous share purchases in the past 60 days, with prices ranging from $2.84 to $2.94, and one sale of 100,000 shares on May 28, 2026 at $2.83.

• · Amendment No. 6 to Schedule 13D filed on June 15, 2026.
• · Transactions in the past 60 days include 31 buy transactions and 1 sell transaction.
• · Largest buy was 248,772 shares on May 11, 2026 at $2.92.
• · Sale of 100,000 shares on May 28, 2026 at $2.83.
• · No single client account of SIA or SFI owns more than 5% of shares outstanding.

15-06-2026

Al Shams Investments, Braemar Hotels & Resorts' largest shareholder with a 9.55% stake (6,513,000 shares), filed an amended Schedule 13D on June 15, 2026, disclosing an open letter to the board condemning the sale of three hotel properties that triggered a $480 million termination fee payable to a company controlled by Chair Monty Bennett. Al Shams vows to pursue legal remedies, nominate a full slate of independent directors for the 2026 Annual Meeting, and calls for the meeting to be held immediately. The stock fell 15% in two days following the announcement, and the share price has declined nearly 90% since the company's separation from Ashford Hospitality Trust, currently trading at $2.10.

• · Al Shams previously sent open letters on May 8, June 2, and June 10, 2026, warning the board not to act without shareholder consent.
• · The $480 million fee exceeds the net proceeds from the hotel sales that triggered it.
• · Braemar is described as 'among the most leveraged lodging REITs in the sector.'
• · Al Shams intends to file a definitive proxy statement on Schedule 14A with the SEC to solicit proxies for the Annual Meeting.
• · The filing was made jointly by Al Shams Investments and Wafic Rida Said as a Schedule 13(d) group.